Cargando…
COVID-19 – Impact on Childhood Haematology Patients
Autores principales: | Wolfs, Tom F.W., Attarbaschi, Andishe, Balduzzi, Adriana, Bernardo, Maria Ester, Bomken, Simon, Borkhardt, Arndt, Bourquin, Jean-Pierre, Dufour, Carlo, Gennery, Andrew, Grainger, John, Hasle, Henrik, Hrusak, Ondrej, Izraeli, Shai, Mechinaud, Francoise, Trka, Jan, Vormoor, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489725/ https://www.ncbi.nlm.nih.gov/pubmed/32984769 http://dx.doi.org/10.1097/HS9.0000000000000465 |
Ejemplares similares
-
Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders
por: Pastorczak, Agata, et al.
Publicado: (2022) -
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
por: Gefen, Nir, et al.
Publicado: (2009) -
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
por: Kalina, Tomas, et al.
Publicado: (2005) -
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group
por: Bomken, Simon, et al.
Publicado: (2018) -
Understanding the cancer stem cell
por: Bomken, S, et al.
Publicado: (2010)